Join us at eCheminfo Euro

eChemInfo workshop

Final Announcement for the eChemInfo Training and Innovation Course in Drug Design 2017 in Milano

This is a final eminder that the Training and Innovation Course in Drug Design will take place at the Department of Pharmaceutical Sciences, University of Milano from Mon, 17 Jul. to Fri, 21 Jul. 2017.

The final program is available at http://www.echeminfo.com/events/drug-design-euro-2017

We will have three exiting key notes:

  • Malaria Drug Discovery Methods, Donatella Taramelli, University of Milan
  • Aspects of Industrial Drug Design, Anna Maria Capelli, Chiesi
  • Design of Cyclopeptidic Drugs, Laura Belvisi / Monica Civera, University of Milan

We are also very happy to be able this year to strongly integrate experimental techniques into the workshop. Stefan Jehle from Bruker BioSpin AG, the leading company in biomolecular NMR spectroscopy, will give a session on “NMR-driven Fragment Based Drug Design”. And we have Anthony Bradley from the Diamond Light Source's XChem project, which provides services for complex structure determination using medium- to high-throughput X-ray. He will give a presentation together with Tim Dudgeon (Informatics Matters) on “Moving from Individual Tools to Complete Workflows”.

And just to remind you on our special setup of the workshop: Use the “bring your own problems” option to directly apply your newly acquired knowledge to your own research, profit from specific advice by the experts and other participants and contribute to innovative approaches for all case studies. You can also present a poster of your work to give the other attendees an overview of your work and foster discussions within the groups.

We would highly appreciate if you could showcase the workshop poster (http://www.echeminfo.com/Milano2017_Poster.pdf) on your notice boards.

Register now at https://goo.gl/au4QBW

 

Dr Thomas Exner is a Chief Scientific Officer (CSO) at Douglas Connect

 

Add new comment

By submitting this form, you accept the Mollom privacy policy.

About Douglas Connect

Douglas Connect manages collaborative projects to achieve goals in scientific research, infrastructure development or service provision. Effective collaboration requires many elements including coordination, culture, communications, common understanding, decision-making and interoperability.

------------------------

MEET US IN SEATTLE, AT THE 10TH WORLD CONGRESS ON ALTERNATIVES AND ANIMAL USE IN THE LIFE SCIENCES, BOOTH 405!

Tags

Latest Tweets

Douglas Connect (2 days ago)
Meet us in Seattle, at the 10th World Congress on Alternatives and Animal Use in the Life Sciences, Booth 405 https://t.co/FiSgRl16wD
Douglas Connect (2 days ago)
RT @barryhardy: Advancing best practice in #risk #assessment #reporting #silico #WC10 #OpenTox #OpenRiskNet @EUToxRisk @DouglasConn https:/…
Douglas Connect (4 days ago)
RT @barryhardy: #WC10 @DouglasConn Discuss with Douglas Connect #OpenTox #Garuda #Interoperability with Time Savings but no Lock-in! https:…
Douglas Connect (4 days ago)
RT @barryhardy: #WC10 discuss with @DouglasConn Team @EU_ToxRisk knowledge management, challenges in validation, commercialisation and regu…
Douglas Connect (4 days ago)
RT @barryhardy: @DouglasConn will be at the #WC10 Meeting in #Seattle Look forward to discussing new developments in #datamanagement #safet…

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com